Disclosure of reason for delay in submission of financial results for the quarter ended December 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Everest Organics has explained to BSE why it delayed filing the reason for late submission of its Q3 FY26 (December 31, 2025) financial results. The actual board meeting for approving the results started late on February 14, 2026 at 8:45 PM, ran into the early hours of February 15, 2026 (ending at 1:00 AM), and the board needed additional information before finalizing the numbers. Despite the late board meeting, the unaudited financial results were uploaded to the BSE portal on February 15, 2026 itself in both PDF and XBRL formats, within the prescribed timeline. What was actually delayed was the separate disclosure explaining the reason for the delay, which the company acknowledges was an unintentional oversight.
This is a procedural compliance filing with no material impact on the business or shareholders. The financial results themselves were submitted on time, the trading window closure was properly handled, and the company has committed to avoiding such delays in future. Investors should not read this as a negative signal about the company's operations or financial health.